Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
ypV46cUMjmMRueCM